Published in TB and Outbreaks Week, October 12th, 1998
"Zanamivir is a new antiviral that stops influenza dead in its tracks," said Prof. Chris Silagy, Flinders Medical Centre, South Australia. "It is given by the inhaled route so the medicine goes straight to where the influenza virus infects the body - in the breathing passages. By inhaling zanamivir, the drug gets to the site of infection faster than taking it by mouth."
New information from two Phase III clinical trials was presented at ICAAC - the 38th Interscience...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week